CATALANO, FABIO
 Distribuzione geografica
Continente #
EU - Europa 639
AS - Asia 108
NA - Nord America 48
SA - Sud America 7
AF - Africa 1
Totale 803
Nazione #
IT - Italia 620
SG - Singapore 46
US - Stati Uniti d'America 42
VN - Vietnam 27
CN - Cina 21
FR - Francia 8
BR - Brasile 5
IN - India 4
CA - Canada 3
HK - Hong Kong 3
MX - Messico 3
AR - Argentina 2
GB - Regno Unito 2
IQ - Iraq 2
UA - Ucraina 2
AT - Austria 1
BD - Bangladesh 1
CH - Svizzera 1
DK - Danimarca 1
DZ - Algeria 1
ES - Italia 1
FI - Finlandia 1
ID - Indonesia 1
IE - Irlanda 1
KR - Corea 1
PH - Filippine 1
SI - Slovenia 1
TH - Thailandia 1
Totale 803
Città #
Genoa 379
Genova 109
Rapallo 75
Vado Ligure 52
Singapore 22
Council Bluffs 9
San Jose 8
Ho Chi Minh City 7
Lauterbourg 7
Ashburn 6
Beijing 4
Hanoi 4
São Paulo 4
Biên Hòa 2
Da Nang 2
Haiphong 2
Hong Kong 2
Kyiv 2
Los Angeles 2
San Juan 2
Santa Clara 2
Basra 1
Bedsted Thy 1
Bengaluru 1
Bordighera 1
Brampton 1
Burlington 1
Bình Phước 1
Centro Municipality 1
Chennai 1
Chicago 1
Chlef 1
City of London 1
Dallas 1
Dublin 1
Elizabeth 1
Elk Grove Village 1
Guadalupe 1
Gurugram 1
Helena 1
Houston 1
Kapurthala Town 1
Khon Kaen 1
Lambari 1
Lanús 1
Lappeenranta 1
Ljubljana 1
London 1
Long An 1
Long Xuyen 1
Madrid 1
Marseille 1
Mexico City 1
Montreal 1
New York 1
Nha Trang 1
Quận Bình Thạnh 1
Rome 1
South Burlington 1
Toronto 1
Vienna 1
Washington 1
Waterbury 1
Yongin-si 1
Ân Thi 1
Totale 746
Nome #
The prognostic role of baseline metabolic tumor burden and systemic inflammation biomarkers in metastatic castration-resistant prostate cancer patients treated with Radium-223: A proof of concept study 165
802TiP Immune tumor microenvironment (TME) in correlation with peripheral blood immune biomarkers as prognostic factor in metastatic renal cell carcinoma (mRCC) patients treated with nivolumab: The multicentric retrospective Meet-URO 18 study 147
Feasibility of multiple immunoexpression assay for immune tumor micrornvironment (I-TME) on matched metastatic and primary renal cell carcinoma (RCC) for patient prognostication and predictiveness to immunotherapy (preliminary analyses of the Meet URO 18 study). 116
Hyperthyroidism in non-seminomatous testicular germ cell tumors: two case reports and literature review 109
Characterization of Tumor and Immune Tumor Microenvironment of Primary Tumors and Metastatic Sites in Advanced Renal Cell Carcinoma Patients Based on Response to Nivolumab Immunotherapy: Preliminary Results from the Meet-URO 18 Study 98
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study) 98
1476P Immunohistochemical (mIHC) analyses of the immune tumor microenvironment (I-TME) in metastatic renal cell carcinoma (mRCC) patients (pts) receiving immunotherapy: Main results from the Meet-URO 18 study 89
Totale 822
Categoria #
all - tutte 3.048
article - articoli 3.048
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.096


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202123 0 0 0 0 0 0 0 0 0 3 8 12
2021/202227 1 0 0 2 1 3 0 8 1 4 2 5
2022/202386 5 6 1 8 12 8 0 14 15 3 12 2
2023/202482 7 5 3 7 2 15 2 2 3 4 7 25
2024/2025197 13 9 2 8 15 14 14 49 11 8 30 24
2025/2026345 44 39 48 37 33 22 34 15 39 34 0 0
Totale 822